Chemet (RECORDATI RARE DISEASES, INC.)
Welcome to the PulseAid listing for the Chemet drug offered from RECORDATI RARE DISEASES, INC.. This Lead Chelating Activity [MoA],Lead Chelator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | RECORDATI RARE DISEASES, INC. |
NON-PROPRIETARY NAME: | succimer |
SUBSTANCE NAME: | SUCCIMER |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lead Chelating Activity [MoA],Lead Chelator [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-08-21 |
END MARKETING DATE: | 0000-00-00 |
Chemet HUMAN PRESCRIPTION DRUG Details:
Item Description | Chemet from RECORDATI RARE DISEASES, INC. |
LABELER NAME: | RECORDATI RARE DISEASES, INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2013-08-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55292-201_32fdbfad-911d-55f6-e054-00144ff88e88 |
PRODUCT NDC: | 55292-201 |
APPLICATION NUMBER: | NDA019998 |
Other SUCCIMER Pharmaceutical Manufacturers / Labelers: